Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Design of Phase II cancer trials for evaluation of cytostatic/cytotoxic agents.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Design of Phase II cancer trials for evaluation of cytostatic/cytotoxic agents.
Design of Phase II cancer trials for evaluation of cytostatic/cytotoxic agents. J Biopharm Stat. 2009; 19(3):524-9.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials, Phase II as Topic
Head and Neck Neoplasms
Humans
Indoles
Research Design
authors with profiles
Ezra Cohen
Theodore Karrison